Back
Pasithea Therapeutics Corp. Stock Price Chart
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
24
KTTA
Pasithea Therapeutics Corp.
Last Price:
$0.74
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
This Company Solves Remote Work with Virtual HQs
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com-
The current trend is relatively stagnant and KTTA is experiencing slight selling pressure.
Pasithea Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Sell |
| 20-day SMA: | 0.87 | Sell |
| 50-day SMA: | 0.99 | Sell |
| 200-day SMA: | 0.87 | Sell |
| 8-day EMA: | 0.66 | Buy |
| 20-day EMA: | 0.41 | Buy |
| 50-day EMA: | 0.2 | Buy |
| 200-day EMA: | 0.06 | Buy |
Pasithea Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 26.66 | Sell |
| Chaikin Money Flow: | -226652 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.02) | Sell |
| Bollinger Bands (100): | (0.66 - 1.06) | Sell |
Pasithea Therapeutics Corp. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pasithea Therapeutics Corp. Stock
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 0.73 while KTTA 8-day simple moving average is 0.82, which is a Sell signal.
-
The stock price of KTTA is 0.73 while Pasithea Therapeutics Corp. 20-day SMA is 0.87, which makes it a Sell.
-
Pasithea Therapeutics Corp. 50-day simple moving average is 0.99 while KTTA share price is 0.73, making it a Sell technically.
-
KTTA stock price is 0.73 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.87, creating a Sell signal.
KTTA Technical Analysis vs Fundamental Analysis
Sell
24
Pasithea Therapeutics Corp. (KTTA)
is a Sell
Is Pasithea Therapeutics Corp. a Buy or a Sell?
-
Pasithea Therapeutics Corp. stock is rated a SellThe current Pasithea Therapeutics Corp. [KTTA] share price is $0.73. The Score for KTTA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Pasithea Therapeutics Corp. Stock Info
Market Cap:
5.4M
Price in USD:
0.73
Share Volume:
327.2K
Pasithea Therapeutics Corp. 52-Week Range
52-Week High:
3.79
52-Week Low:
0.28
Sell
24
Pasithea Therapeutics Corp. (KTTA)
is a Sell
Pasithea Therapeutics Corp. Share Price Forecast
-
What is the Pasithea Therapeutics Corp. stock price today?The Pasithea Therapeutics Corp. stock price is 0.73 USD today.
-
Will KTTA stock go up or go down?Pasithea Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pasithea Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pasithea Therapeutics Corp. is overvalued.
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 0.73 while KTTA 8-day exponential moving average is 0.66, which is a Buy signal.
-
The stock price of KTTA is 0.73 while Pasithea Therapeutics Corp. 20-day EMA is 0.41, which makes it a Buy.
-
Pasithea Therapeutics Corp. 50-day exponential moving average is 0.20 while KTTA share price is 0.73, making it a Buy technically.
-
KTTA stock price is 0.73 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of Pasithea Therapeutics Corp.
Is Pasithea Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Pasithea Therapeutics Corp.
Should I short Pasithea Therapeutics Corp. stock?
-
KTTA Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Pasithea Therapeutics Corp. is a Buy
-
Pasithea Therapeutics Corp. Relative Strength Index (RSI) is 26.66, which suggest Pasithea Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for Pasithea Therapeutics Corp. is (0.8 - 1.02), which suggest Pasithea Therapeutics Corp. is a Sell
-
The Bollinger Bands (100) for Pasithea Therapeutics Corp. is (0.66 - 1.06), which suggest Pasithea Therapeutics Corp. is a Sell
* Pasithea Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.